Store
Molecular Diagnostics Quarterly Datastream, 2025
Publication Date: April 2, 2025
Tags: COVID-19, Diagnostics Market Research, Immunoassay, In Vitro Diagnostics (IVD), IVD, Molecular, Oncology and Cancer, POC, Point of Care
SKU: 25-029KA
Important Note: The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports.
Stay Ahead with the Latest Information: Subscribers will receive data updates after each financial quarter for one year, totaling four updates (Q4 2024, Q1 2025, Q2 2025, Q3 2025). These updates are provided in an Excel spreadsheet, making them easily accessible for your marketing, business development, product management teams, and company executives.
With this data, your company will always have the most current information on the size and growth of the molecular diagnostics market. Each update also includes insights on how fluctuations in major global currencies have impacted real growth in the examined markets. Corporate leadership can use the Datastream to guide quarterly market share assessments and measure your company’s growth against the industry.
Quarterly Market Estimates Include:
- Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB, and Other Infections)
- Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
- Molecular Genetic Testing (Inherited Diseases and NIPT)
- Molecular Transplantation
- Molecular NAT Blood Banking Tests
- Molecular Point of Care Tests
- Molecular COVID Testing
This comprehensive data ensures your company remains informed and competitive in the dynamic molecular diagnostics market.
Related products
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
Price range: $3,000.00 through $4,500.00
In Vitro Diagnostic (IVD) Trends and Market Update: November 2023
November 7, 2023
As in vitro diagnostic (IVD) testing returns to its vital role in healthcare, it remains a cornerstone in medical practice, providing crucial insights for physicians, from diagnosis to precision medicine. While COVID-19 testing sees a decline, it continues to influence total revenues for 2023. In this ever-changing landscape, characterized by new products, shifts in global…
Price range: $3,750.00 through $5,625.00
Cell and Gene Therapy Market and Deals Analysis, 2023
May 22, 2023
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…
Price range: $4,000.00 through $6,000.00
